Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention
Biotech rally fueled by outbreak concerns, promising flu vaccine data, and potential FDA leadership changes Moderna (MRNA) shares climbed sharply ...
Tag: MRNA
Moderna’s Flu Vaccine Back Under FDA Review After Key Modifications
Regulatory reversal boosts investor confidence and puts mRNA flu shot on track for potential approval this year Moderna (MRNA) has ...
Moderna Slashes 2025 Sales Forecast Amid Weak Vaccine Demand
Slow RSV shot adoption and waning COVID-19 vaccine sales weigh on revenue projections Moderna (MRNA) announced a $1 billion reduction ...
